ClinicalTrials.Veeva

Menu

PREoperativ Study of Exercise Training (PRESET-RCT)

J

Jesper Frank Christensen, PhD

Status

Active, not recruiting

Conditions

GastroEsophageal Cancer

Treatments

Behavioral: Exercise training

Study type

Interventional

Funder types

Other

Identifiers

NCT03490565
PRESET-RCT

Details and patient eligibility

About

Background Patients undergoing resection for gastro-esophageal (GE)-cancer are subjected to high burden of disease and treatment-specific morbidities with potential detrimental impact on survival and quality of life. Exercise training is a promising strategy to improve physical functional before and after tumor resection, but it is not established if this translates into lower risk of peri- and post-operative complications, improved treatment tolerance.

Objectives:

  • To explore the effect a preoperative exercise-training intervention on the risk of treatment failure, defined as the risk of not reaching surgery, in patients diagnosed with operable GE cancer.
  • To explore the effect of preoperative exercise training on median time to tumor progression (disease free survival), and overall survival
  • To explore the effect of preoperative exercise training on the risk of treatment complications
  • To explore the effect of preoperative exercise training on health related quality of life, anxiety and depression,cardiopulmonary fitness, muscle strength, and body composition

Subjects and Methods In total, 310 GE-cancer patients will be included in the study and randomly allocated to pre-operative exercise training (n=155) or usual care control (n=155). All participants will undergo 2 study visits; assessed for cardiopulmonary fitness; muscle strength, body composition; blood sample (50 ml); quality of life by questionnaires; physical function; and blood volume profile.

Quality of life will be assessed by questionnaires by self-report three times (at 12, 24, and 36 months after diagnosis), and we will collect data from medical records regarding mortality and disease recurrence up to 36 months after diagnosis.

Treatment arms:

The intervention-group will be prescribed 2-3 weekly supervised exercise training for a total of 12 weeks before surgery during neo-adjuvant chemotherapy. The control group will follow current usual care guidelines. After surgery during adjuvant chemotherapy, both groups will be referred to municipality-based rehabilitation.

Enrollment

310 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with histologically verified, resectable adenocarcinoma of the esophagus, stomach or gastro-esophageal junction

Exclusion criteria

  • Deemed inoperable at the point of diagnoses
  • Pregnancy
  • Any other known malignancy requiring active treatment
  • Not eligible for preoperative chemo- or chemoradiotherapy
  • Performance status > 1
  • Physical disabilities precluding physical testing and/or exercise
  • Inability to read and understand Danish

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

310 participants in 2 patient groups

EX group
Active Comparator group
Description:
Exercise training
Treatment:
Behavioral: Exercise training
CON-group
No Intervention group
Description:
Usual Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems